Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

Saved in:
Bibliographic Details
Title: Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Authors: Barr EK; Department of Pediatrics, Texas Tech University Health Sciences, Lubbock, Texas, USA., Naranjo A; Department of Biostatistics, University of Florida Children's Oncology Group Statistics and Data Center, Gainesville, Florida, USA., Twist CJ; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Tenney SC; Department of Biostatistics, University of Florida Children's Oncology Group Statistics and Data Center, Gainesville, Florida, USA., Schmidt ML; Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Gastier-Foster J; Department of Pediatrics and Pathology/Immunology, Baylor College of Medicine, Houston, Texas, USA., Adkins ES; Department of Pediatrics, Palmetto Health-USC Medical Group, Columbia, South Carolina, USA., Mattei P; Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Handler MH; Department of Neurosurgery, Children's Hospital Colorado, Aurora, Colorado, USA., Matthay KK; Department of Pediatrics, University of California San Francisco School of Medicine, San Francisco, California, USA., Park JR; Department of Oncology, St.Jude Children's Research Hospital, Memphis, Tennessee, USA., Maris JM; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Desai AV; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA., Cohn SL; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31089. Date of Electronic Publication: 2024 May 31.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1545-5017
DOI:10.1002/pbc.31089